Skip to main navigation Skip to search Skip to main content

Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement

  • John Jeongseok Yang
  • , Tae Sung Park
  • , Seung Tae Lee
  • , Ja Young Seo
  • , Seung Hwan Oh
  • , Eun Hae Cho
  • , Sabine Strehl
  • , Nora Mühlegger
  • , Michael N. Dworzak
  • , Jan Zuna
  • , Dagmar Pospisilova
  • , Claus Meyer
  • , Rolf Marschalek
  • , Hee Jin Kim
  • , Sun Hee Kim
  • Kyung Hee University
  • Sungkyunkwan University
  • Inje University
  • Green Cross Genome Corporation
  • Children's Cancer Research Institute
  • Medical University of Vienna
  • Charles University
  • Department of Paediatrics
  • Goethe University Frankfurt

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)11-13
Number of pages3
JournalHaematologica
Volume99
Issue number1
DOIs
StatePublished - 1 Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CASC5
  • Chromosome 3 abnormality
  • Hematologic malignancies
  • MLL
  • T(11;15)

Cite this